ARTL (Artelo Biosciences) Net Margin %: 0.00% (As of Mar. 2026)

What is Artelo Biosciences Net Margin %?

Artelo Biosciences ARTL -1.75% 31 Net Margin % is 0.00% as of Mar. 2026. GuruFocus rates ARTL with a GF Score™ of 31/100. The stock has 2 warning signs investors should review. Among 946 Biotechnology companies, Artelo Biosciences ranks worse than 105708.14% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Artelo Biosciences's Net Income for the three months ended in Mar. 2026 was $-2.96 Mil. Artelo Biosciences's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Artelo Biosciences's net margin for the quarter that ended in Mar. 2026 was 0.00%.

The historical rank and industry rank for Artelo Biosciences's Net Margin % or its related term are showing as below:

ARTL's Net Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -88.815
* Ranked among companies with meaningful Net Margin % only.

Artelo Biosciences (NAS:ARTL) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Artelo Biosciences Net Margin % Related Terms

Artelo Biosciences Net Margin % Historical Data

* Premium members only.

The historical data trend for Artelo Biosciences's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Artelo Biosciences Net Margin % Chart

Artelo Biosciences Annual Data

Trend

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Dec22

Dec23

Dec24

Dec25

Net Margin %

Get a 7-Day Free Trial

0.00

Artelo Biosciences Quarterly Data
	May21	Aug21	Nov21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Net Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

ARTL vs RNAZ, GLMD, DCOY: Net Margin % Comparison

For the Biotechnology subindustry, Artelo Biosciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Artelo Biosciences Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Artelo Biosciences's Net Margin % distribution charts can be found below:

* The bar in red indicates where Artelo Biosciences's Net Margin % falls into.

Save Embed

31GF Score

Artelo Biosciences Inc ARTL

Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Artelo Biosciences Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Artelo Biosciences's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin	=	Net Income (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-12.879	/	0
	=	%

Artelo Biosciences's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin	=	Net Income (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-2.958	/	0
	=	%

Frequently Asked Questions Learn more about Net Margin % →

What does a Net Margin % of 0.00% mean?

Artelo Biosciences (ARTL) has a Net Margin % of 0.00% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Artelo Biosciences and its competitors. According to the industry distribution chart, Artelo Biosciences ranks #999999 out of 946 companies in the Biotechnology industry.

Is Artelo Biosciences' Net Margin % too high?

Artelo Biosciences' current Net Margin % is 0.00%. Based on the distribution chart, Artelo Biosciences ranks #999999 out of 946 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Artelo Biosciences has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.

How does Artelo Biosciences' Net Margin % compare to RNAZ and GLMD?

According to the Biotechnology industry distribution chart, Artelo Biosciences ranks #999999 out of 946 companies for Net Margin %. This places Artelo Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Net Margin % for a Biotechnology company?

A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Net Margin % mean?

A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Artelo Biosciences and its competitors. Artelo Biosciences's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Artelo Biosciences stock overvalued right now?

Artelo Biosciences (ARTL) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Artelo Biosciences' overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Net Margin % calculated?

Net Margin % is calculated from a company's financial statements. For Artelo Biosciences (ARTL), the current Net Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Artelo Biosciences Business Description

Industry Healthcare Biotechnology

Comparable Companies RNAZ GLMD DCOY CDT PULM ADIL MBIO MTNB ALZN DRMA VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address 505 Lomas Santa Fe, Suite 160, Solana Beach, CA, USA, 92075

Website https://www.artelobio.com

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

31GF Score

Get the complete analysis for ARTL

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.13

Price

View ARTL Analysis

See Net Margin % data for all stocks →